Company Filing History:
Years Active: 2002-2003
Title: Innovator Spotlight: Wen-Lung Yeh
Introduction: Wen-Lung Yeh is a notable inventor based in Ontario, CA, recognized for his contributions to the pharmaceutical industry. With a total of three patents under his name, Yeh has made significant advancements in the synthesis of pharmaceutical compounds, particularly histamine dihydrochloride. His innovative methods have enhanced the quality and efficiency of pharmaceutical production.
Latest Patents: Among his latest patents, the most significant is related to the synthesis of histamine dihydrochloride. This invention encompasses a two-step non-enzymatic synthetic method to prepare pharmaceutical-grade histamine dihydrochloride. The process involves the non-enzymatic decarboxylation of histidine, followed by a step-wise conversion to the dihydrochloride salt form. Yeh's invention ensures that the final product meets strict pharmaceutical standards, containing less than 0.8% L-histidine HCl monohydrate, 0.1% individual chromatographic impurities, and 2% total impurities, making it suitable for medical use.
Career Highlights: Wen-Lung Yeh's achievements in the field of pharmaceuticals are notable. As a member of Maxim Pharmaceuticals, Inc., he has played an essential role in advancing drug synthesis techniques. His expertise and innovative thinking have resulted in patents that not only improve existing processes but also pave the way for new developments in drug formulation.
Collaborations: Throughout his career, Yeh has collaborated with esteemed colleagues such as Casimir Antczak and Jeffry David McGolrick. These collaborations have been pivotal in enhancing research outcomes and expanding the reach of their innovations within the pharmaceutical sector.
Conclusion: Wen-Lung Yeh stands out as an influential inventor in the pharmaceutical field, particularly through his work on histamine dihydrochloride synthesis. His patented innovations showcase his dedication to improving pharmaceutical practices. With his continued collaboration and expertise at Maxim Pharmaceuticals, Inc., Wen-Lung Yeh is poised to drive further advancements in this critical area of healthcare.